Inhibace · DIN 01911481 · 5 mg · tablet
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Inhibace · DIN 01911481
Manufacturer: Cheplapharm Arzneimittel GmbH; listing date 1996-10-01
Daily cost (source): $1.1698
Health Canada: Marketed since 2019-08-19 · brand INHIBACE · ATC C09AA08 CILAZAPRIL · form Tablet · route Oral · ingredients CILAZAPRIL (CILAZAPRIL MONOHYDRATE) 5 MG · company Cheplapharm arzneimittel gmbh · schedule Prescription
Ministry pays: $0.4989 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01911481)
Source record
DIN 01911481: Inhibace
Raw flags: chronicUseMed=Y, sec3=Y
Item: 240800191; group id 318; item number 0707; lccId None; manufacturer id CHE
Source form: Tab; strength: 5mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $1.1698; ministry $0.4989
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01911481
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13834
Interchangeable products
Apo-Cilazapril · DIN 02291150 · $0.4989
Mylan-Cilazapril · DIN 02283794 · $0.4989
Shortage status: not checked (no credentials)